Search for a trial

A PHASE III, MULTICENTER, RANDOMIZED,
DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY
TO ASSESS THE EFFICACY AND SAFETY OF
BALOXAVIR MARBOXIL IN COMBINATION WITH A
NEURAMINIDASE INHIBITOR VERSUS A
NEURAMINIDASE INHIBITOR ALONE IN
HOSPITALIZED PATIENTS WITH SEVERE
INFLUENZA

This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir, zanamivir, or peramivir) compared with a matching placebo in…